{"id":"W2115180385","doi":"10.1586/17512433.2.2.181","title":"Lipid-based delivery of CpG oligodeoxynucleotides for cancer immunotherapy","year":2009,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"CpG Oligodeoxynucleotide; Medicine; Biodistribution; Immunotherapy; Immune system; Cancer; Cancer research; Pharmacology; Cancer immunotherapy; Clinical trial; Monoclonal antibody; Immunology; Antibody; In vitro; Biology; Internal medicine; Biochemistry; DNA methylation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056537,0.0001600159,0.0007015124,0.00002966079,0.0000196245,0.000001929352,0.0003424112,0.0001624615,0.000264674],"category_scores_gemma":[0.0001475603,0.0001328296,0.0005740801,0.00006248138,0.0001533171,0.000004272516,0.00002836537,0.00009254782,0.000002559419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006127731,"about_ca_system_score_gemma":0.0002090168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000197886,"about_ca_topic_score_gemma":0.000003452918,"domain_scores_codex":[0.9981703,0.0001820444,0.001049102,0.0003093356,0.00009156355,0.0001976892],"domain_scores_gemma":[0.9987465,0.0001456834,0.0004387994,0.0002679687,0.0003323647,0.00006870231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008620091,0.000397716,0.0003501629,0.0004635822,0.000179606,7.317914e-7,0.000007828893,0.00001765418,0.6832922,0.00001580492,0.1792996,0.1351131],"study_design_scores_gemma":[0.001501819,0.001907651,0.0008597159,0.0006124893,0.00005773504,9.263886e-7,0.000003600138,0.00008638408,0.4864263,0.00002477411,0.5083583,0.0001602907],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.6270218,0.3613243,0.001822007,0.005318617,0.002943854,0.001110085,0.00007197714,0.00002389401,0.0003634226],"genre_scores_gemma":[0.4595152,0.4870182,0.001850939,0.04960504,0.00169693,0.0001502052,0.00004361165,0.00002467065,0.00009522791],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.3290587,"threshold_uncertainty_score":0.5416633,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04964886940516828,"score_gpt":0.4663918525853699,"score_spread":0.4167429831802016,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}